Silva Pharmaceuticals Limited (DSE:SILVAPHL)

Market Cap	1.31B
Revenue (ttm)	356.99M -28.4%
Net Income	-145.41M
EPS	-1.07
Shares Out	136.50M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	285,597
Average Volume	317,181
Open	n/a
Previous Close	9.50
Day's Range	9.50 - 9.80
52-Week Range	7.60 - 14.40
Beta	-0.04
RSI	45.65
Earnings Date	Apr 28, 2026

About Silva Pharmaceuticals

Silva Pharmaceuticals Limited engages in manufacturing and marketing of pharmaceuticals finished products in Bangladesh and internationally. The company offers drugs for various categories, including antibiotics, analgesics, anti-diabetics, narcotics, anti-pyretics, anti-inflammatory, anti ulcerants, antiemetic, gastroprokinetic, antihistamine, anti-spasmodic expectorants, and vitamins and mineral. It also provides pharmaceutical products in therapeutic areas, such as anemias and other blood disorders, central nervous system, gastro- intestinal...

• Industry: Pharmaceutical Preparations
• Founded: 2001
• Employees: 624
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: SILVAPHL

Financial Performance

In fiscal year 2025, Silva Pharmaceuticals's revenue was 383.65 million, a decrease of -36.02% compared to the previous year's 599.66 million. Losses were -132.95 million, 106.2% more than in 2024.